Scantox Ballerup ApS: Financial statements 2016
CVR: 34724938
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
Scantox Ballerup ApS (CVR 34724938) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 8,457,376 and a net result of DKK 1,835,155 compared with DKK 3,564,681 the year before. That is a decrease of 2.7% compared with the year before. Equity in the 2016 report amounted to DKK 4,084,713. The solvency ratio was 32.6%.
- Gross Profit
- DKK 8,457,376
- Profit/Loss
- DKK 1,835,155
- Equity
- DKK 4,084,713
- Total Assets
- DKK 12,547,989
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 8.5 mio. | 1.8 mio. | 4.1 mio. | - |
| 2015 | - | 8.7 mio. | 3.6 mio. | 2.2 mio. | - |
| 2014 | - | 7.2 mio. | 90 t. | 215 t. | - |
Official annual report
Find more companies like Scantox Ballerup ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
Scantox Ballerup ApS has published its annual report for 2015. Gross profit came to DKK 8,691,905, and the net result was DKK 3,564,681.
About Scantox Ballerup ApS
Scantox Ballerup ApS is a Danish company of the type Anpartsselskab based in Ballerup, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SOLURAL PHARMA ApS. The management consists of Helle Kirstein Erichsen. The board consists of Jeanet Løgsted Nielsen (chair) and Emil Staal Bergander. The company is owned by Scantox Denmark ApS. The company has 14 employees (2026). In 2025, the company reported a gross profit of DKK 13,349,106 and a net result of DKK -1,931,049 compared with DKK 255,010 the year before. Equity in the 2025 report amounted to DKK -1,539,321.